Neurology

The SORT-IN-2 trial is a Phase 1b/2a proof-of-concept study evaluating the therapeutic potential of VES001,…

Neurology News Network. for the week ending January 11, 2025. : Source: Neurology Read More

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 10,…

The professor and chair of the Department of Molecular Pathobiology at NYU Langone provided a…

Between those infected and uninfected with COVID-19, investigators observed no differences in symptom trajectories, assessed…

The senior vice president of research at The ALS Association discussed the need for standardizing…

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Russell Lebovitz, MD,…

Results from the open-label phase 1/2 study of tividenofusp alfa demonstrated positive effects on evidence-based…

Masoud Toloue, chief executive officer at Quanterix, and Nicholas J. Ashton, PhD, senior director of…

The primary audience for the new appropriate use criteria is dementia specialists who dedicate a…